Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ |
Check the appropriate box:
- Preliminary Proxy Statement
- Confidential, for Use of the Commission Only (as permitted by Rule14a-6(e)(2))
- Definitive Proxy Statement
- Definitive Additional Materials
- Soliciting Material Pursuant to§240.14a-12
Nektar Therapeutics
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
- No fee required.
- Fee computed on table below per Exchange Act Rules14a-6(i)(1) and 0-11.
- Title of each class of securities to which transaction applies:
- Aggregate number of securities to which transaction applies:
- Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
- Proposed maximum aggregate value of transaction:
- Total fee paid:
- Fee paid previously with preliminary materials.
- Check box if any part of the fee is offset as provided by Exchange Act Rule0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
- Amount Previously Paid:
- Form, Schedule or Registration Statement No.:
- Filing Party:
- Date Filed:
Table of Contents
NEKTAR THERAPEUTICS
455 Mission Bay Boulevard South
San Francisco, California 94158
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JUNE 10, 2021
AT 2:00 P.M. PACIFIC TIME
Dear Stockholder:
You are cordially invited to attend the 2021 Annual Meeting of Stockholders of Nektar Therapeutics, a Delaware corporation, which will be held by live webcast only. The 2021 Annual Meeting will be held on Thursday, June 10, 2021, at 2:00 p.m. for the following purposes:
- To elect three directors with terms to expire at the 2024 Annual Meeting of Stockholders.
- To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of authorized for issuance under the plan by 5,000,000.
- To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
- To approve anon-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote).
- To conduct any other business properly brought before the 2021 Annual Meeting.
These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. The record date for the 2021 Annual Meeting is April 12, 2021. Only stockholders of record at the close of business on that date are entitled to notice of, and to vote at, the 2021 Annual Meeting or any adjournment thereof.
Due to the public health and travel concerns our stockholders may have related to the coronavirus (COVID-19) and the protocols that federal, state, and local governments may impose, we have elected to hold the Annual Meeting of Stockholders solely by means of remote communication. The webcast of the Annual Meeting will begin promptly at 2:00 p.m. Pacific Time.
To participate in the live webcast, please visit www.virtualshareholdermeeting.com/NKTR2021. You will need the control number included on your Notice, proxy card, or voting instruction form. We encourage you to access the meeting prior to the start time.
Your vote is very important. Whether or not you participate in the 2021 Annual Meeting, which will be held by live webcast on the day of the meeting, it is important that your shares be represented. You may vote your proxy on the Internet, by phone or by mail in accordance with the instructions in the Notice of Availability of Proxy Materials.
On behalf of the Board of Directors, thank you for your participation in this important annual process.
By Order of the Board of Directors
/s/ Mark A. Wilson Mark A. Wilson
Senior Vice President, General Counsel and Secretary
San Francisco, California
April 30, 2021
YOU ARE CORDIALLY INVITED TO ATTEND THE ANNUAL MEETING VIA LIVE WEBCAST ON THE DAY OF THE MEETING. WHETHER OR NOT YOU EXPECT TO ATTEND THE ANNUAL MEETING, PLEASE VOTE ON THE INTERNET, BY PHONE OR BY MAIL AS INSTRUCTED IN THE NOTICE OF AVAILABILITY OF PROXY MATERIALS, AS PROMPTLY AS POSSIBLE IN ORDER TO ENSURE YOUR REPRESENTATION AT THE MEETING. EVEN IF YOU HAVE VOTED BY PROXY, YOU MAY STILL VOTE DURING THE LIVE WEBCAST IF YOU ATTEND THE ANNUAL MEETING. PLEASE NOTE, HOWEVER, THAT IF YOUR SHARES ARE HELD OF RECORD BY A BROKER, BANK OR OTHER NOMINEE AND YOU WISH TO VOTE AT THE ANNUAL MEETING, YOU MUST OBTAIN A PROXY ISSUED IN YOUR NAME FROM THAT RECORD HOLDER.
Table of Contents
TABLE OF CONTENTS | |
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES | 1 |
PROPOSAL 1: ELECTION OF DIRECTORS | 7 |
PROPOSAL 2: APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE PLAN | 9 |
PROPOSAL 3: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 17 |
PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION | 18 |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 19 |
DELINQUENT SECTION 16(A) REPORTS | 21 |
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 22 |
INFORMATION ABOUT THE BOARD OF DIRECTORS | 23 |
THE BOARD OF DIRECTORS | 23 |
DIRECTORS CONTINUING IN OFFICE UNTIL THE 2022 ANNUAL MEETING | 23 |
DIRECTORS CONTINUING IN OFFICE UNTIL THE 2023 ANNUAL MEETING | 23 |
CURRENT DIRECTORS NOMINATED FOR REELECTION TO SERVE UNTIL THE 2024 ANNUAL MEETING | 24 |
MEETINGS OF THE BOARD OF DIRECTORS | 25 |
CORPORATE GOVERNANCE | 25 |
BOARD LEADERSHIP STRUCTURE | 26 |
RISK OVERSIGHT | 26 |
INDEPENDENCE OF THE BOARD OF DIRECTORS | 28 |
INFORMATION REGARDING THE COMMITTEES OF THE BOARD OF DIRECTORS | 28 |
STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS | 35 |
CODE OF BUSINESS CONDUCT AND ETHICS | 35 |
ORGANIZATION AND COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION | 35 |
DIRECTOR COMPENSATION TABLE | 36 |
COMPENSATION DISCUSSION AND ANALYSIS | 38 |
COMPENSATION COMMITTEE REPORT | 59 |
SUMMARY COMPENSATION TABLE-FISCAL2018-2020 | 60 |
DESCRIPTION OF EMPLOYMENT AGREEMENTS | 61 |
GRANTS OF PLAN BASED AWARDS IN 2020 | 62 |
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END FOR 2020 | 65 |
OPTION EXERCISES AND STOCK VESTED IN 2020 | 68 |
POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL | 68 |
INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 73 |
PRE-APPROVAL POLICIES AND PROCEDURES | 73 |
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | 73 |
OTHER MATTERS | 75 |
ADDITIONAL INFORMATION | 75 |
Table of Contents
NEKTAR THERAPEUTICS
455 Mission Bay Boulevard South
San Francisco, California 94158
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JUNE 10, 2021
AT 2:00 P.M. PACIFIC TIME
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES
Due to the public health and travel concerns our stockholders may have related to the coronavirus (COVID-19) and the protocols that federal, state, and local governments may impose, we have elected to hold the Annual Meeting of Stockholders solely by means of remote communication.
WHY AM IRECEIVING THESE MATERIALS?
We sent you a Notice of Availability of Proxy Materials (the "Notice") because the board of directors of Nektar Therapeutics, a Delaware corporation ("Nektar," the "Company," "we" or "us"), is soliciting your proxy to vote at our 2021 annual meeting of stockholders (the "Annual Meeting") to be held solely by live webcast on June 10, 2021 at 2:00 p.m. There will be no in-person meeting. We invite you to attend the Annual Meeting by live webcast to vote on the proposals described in this proxy statement. However, you do not need to attend the live webcast meeting to vote your shares. Instead, you may vote by proxy over the Internet or by phone by following the instructions provided in the Notice or, if you request printed copies of the proxy materials by mail, you may vote by mail. Please visit our website at www.nektar.com for updated information related to the Annual Meeting. As always, we encourage you to vote your shares prior to the Annual Meeting.
The webcast of the Annual Meeting will begin promptly at 2:00 p.m. Pacific Time. To participate in the live webcast, please visit www.virtualshareholdermeeting.com/NKTR2021.You will need the control number included on your Notice, proxy card, or voting instruction form. We encourage you to access the meeting prior to the start time.
The Notice was first sent or made available on or about April 30, 2021 to all stockholders of record entitled to vote at the Annual Meeting.
WHO CAN VOTE AT THE ANNUAL MEETING?
Only stockholders of record at the close of business on April 12, 2021 will be entitled to vote at the Annual Meeting. On this record date, there were 182,296,922 shares of common stock outstanding and entitled to vote.
Stockholder of Record: Shares Registered in Your Name
If, on April 12, 2021, your shares were registered directly in your name with our transfer agent, Computershare Inc., then you are a stockholder of record. The Notice will be sent to you by mail directly by us. As a stockholder of record, you may vote remotely at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting remotely, we urge you to vote on the Internet or by phone as instructed in the Notice or by proxy by mail by requesting a paper copy of the proxy materials as instructed in the Notice to ensure your vote is counted.
1
Attachments
- Original document
- Permalink
Disclaimer
Nektar Therapeutics published this content on 30 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 April 2021 22:32:04 UTC.